About
Sepsis Diagnostics
Areas of Focus
Categories
DiagnosticsBiotech
Clinical Trials (6)
View allTotal Trials
6
As Lead Sponsor
6
As Collaborator
0
Total Enrollment
2,532
By Phase
NA: 1
By Status
COMPLETED: 4RECRUITING: 1WITHDRAWN: 1
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT06637904Lead Sponsor
TriVerity™ for Improved Management of Emergency Department (ED) Patients With Suspected Infections
NARecruiting
300 participants
Started: Nov 8, 2024 · Completed: Mar 31, 2025
NCT05639504Lead Sponsor
Sepsis Prognosis and Diagnosis in the Emergency Department (SPEED)
N/AWithdrawn
Started: Dec 31, 2022 · Completed: May 31, 2023
NCT04414189Lead Sponsor
Clinical Validation of HostDx Sepsis™ on NanoString; a Prospective Observational Validation Trial
N/ACompleted
200 participants
Started: Jun 7, 2020 · Completed: Oct 19, 2021
NCT04094818Lead Sponsor
TriVerity in the Diagnosis and Prognosis of Emergency Department Patients With Suspected Infections and Suspected Sepsis
N/ACompleted
1,441 participants
Started: Feb 28, 2020 · Completed: Sep 30, 2024
NCT03744741Lead Sponsor
HostDx Sepsis in the Diagnosis and Prognosis of Emergency Department Patients With Suspected Infections: a Multicenter Pilot Study
N/ACompleted
585 participants
Started: Jul 23, 2018 · Completed: Jan 20, 2020
Locations (1)
Headquarters
Sunnyvale, CA, United States
Map
Loading map...